https://doi.org/10.1007/978-1-0716-1987-2_13. ISBN: 978-1-0716-1986-5.

2. Miller J.P. Inflammatory bowel disease in pregnancy: A review. J R Soc Med. 1986; 79(4): 221–25.

https://doi.org/10.1177/014107688607900410. PMID: 2871190. PMCID: PMC1290279.

3. de Lima-Karagiannis A., Zelinkova-Detkova Z., van der Woude C.J. The effects of active IBD during pregnancy in the era of novel IBD therapies. Am J Gastroenterol. 2016; 111(9): 1305–12.

https://doi.org/10.1038/ajg.2016.254. PMID: 27349339.

4. Watanabe C., Nagahori M., Fujii T. et al. Non-adherence to medications in pregnant ulcerative colitis patients contributes to disease flares and adverse pregnancy outcomes. Dig Dis Sci. 2021; 66(2): 577–86.

https://doi.org/10.1007/s10620-020-06221-6. PMID: 32249373.

5. Puri A., Bharadwaj V., Sachdeva S. Extent of disease is a major outcome predictor in patients with ulcerative colitis and pregnancy. Indian J Gastroenterol. 2015; 34(2): 108–11.

https://doi.org/10.1007/s12664-015-0542-y. PMID: 25895048.

6. Getahun D., Fassett M.J., Longstreth G. et al. Association between maternal inflammatory bowel disease and adverse perinatal outcomes. J Perinatol. 2014; 34(6): 435–40.

https://doi.org/10.1038/jp.2014.41. PMID: 24651735.

7. Bortoli A., Pedersen N., Duricova D. et al. Pregnancy outcome in inflammatory bowel disease: Prospective European case-control ECCO – EpiCom study, 2003–2006. Aliment Pharmacol Ther. 2011; 34(7): 724–34.

https://doi.org/10.1111/j.1365-2036.2011.04794.x. PMID: 21815900.

8. Riis L., Vind I., Politi P. et al. Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol. 2006; 101: 1539–45.

https://doi.org/10.1111/j.1572-0241.2006.00602.x. PMID: 16863558.

9. Dubinsky M.., Abraham B, Mahadevan U. Management of the pregnant IBD patient. Inflamm Bowel Dis. 2008; 14: 1736–50.

https://doi.org/10.1002/ibd.20532. PMID: 18626967.

10. Abramson D., Jankelson I.R., Milner L.R. Pregnancy in idiopathic ulcerative colitis. Am J Obstet Gynecol. 1951; 61: 121–29.

https://doi.org/10.1016/0002-9378(51)90014-2. PMID: 14799518.

11. Willoughby C.P., Truelove S.C. Ulcerative colitis and pregnancy. Gut. 1980; 21(6): 469–74.

https://doi.org/10.1136/gut.21.6.469. PMID: 6107262. PMCID: PMC1419661.

12. Greenfield C., Pounder R.E., Craft I.L. et al. Severe ulcerative colitis during successful pregnancy. Postgrad Med J. 1983; 59: 459–61.

https://doi.org/10.1136/pgmj.59.693.459. PMID: 6622331. PMCID: PMC2417568.

13. Bohe M.G., Ekelund G.R., Genell S.N. et al. Surgery for fulminating colitis during pregnancy. Dis Colon Rectum. 1983; 26(2): 119–22.

https://doi.org/10.1007/BF02562590. PMID: 6822171.

14. Anderson J.B., Turner G.M., Williamson R.C. Fulminant ulcerative colitis in late pregnancy and the puerperium. J R Soc Med. 1987; 80(8): 492–94.

https://doi.org/10.1177/014107688708000812. PMID: 3656334. PMCID: PMC1290955.

15. Beniada A., Benoist G., Maurel J., Dreyfus M. Inflammatory bowel disease and pregnancy: Report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod. 2005; 34(6): 581–88.

https://doi.org/10.1016/s0368-2315(05)82883-2. PMID: 16208201.

16. Haq A.I., Sahai A., Hallwoth S. et al. Synchronous colectomy and cesarean section for fulminant ulcerative colitis: Case report and review of the literature. Int J Color Dis. 2006; 21(5): 465–69.

https://doi.org/10.1007/s00384-005-0027-z. PMID: 16133002.

17. Orabona R., Valcamonico A., Salemme M. et al. Fulminant ulcerative colitis in a healthy pregnant woman. World J Gastroenterol. 2015; 21(19): 6060–64.

https://doi.org/10.3748/wjg.v21.i19.6060. PMID: 26019473. PMCID: PMC4438043.

18. Uchino M., Ikeuchi H., Matsuoka H. et al. Surgery for severe ulcerative colitis during pregnancy: Report of two cases. Case Rep Gastroenterol. 2015; 9(1): 74–80.

https://doi.org/10.1159/000381141. PMID: 25960728. PMCID: PMC4410590.

19. Brunelli R., Perrone S., Perrone G. et al. New-onset ulcerative colitis in pregnancy associated to toxic megacolon and sudden fetal decompensation: Case report and literature review. J Obstet Gynaecol Res. 2019; 45(7): 1215–21.

https://doi.org/10.1111/jog.13996. PMID: 31064034.

20. Cappell M.S., Colon V.J., Sidhom O.A. A study at 10 medical centers of the safety and efficacy of 48 flexible sigmoidoscopies and 8 colonoscopies during pregnancy with follow-up of fetal outcome and with comparison to control groups. Dig Dis Sci. 1996; 41(12): 2353–61.

https://doi.org/10.1007/BF02100127. PMID: 9011442.

21. Hartgill T.W., Bergersen T.K., Pirhonen J. Core body temperature and the thermoneutral zone: A longitudinal study of normal human pregnancy. Acta Physiol (Oxf). 2011; 201(4): 467–74.

https://doi.org/10.1111/j.1748-1716.2010.02228.x. PMID: 21087419.

22. Pillay V., Savage N., Laburn H. Interleukin-1 receptor antagonist in newborn babies and pregnant women. Pflugers Arch. 1993; 424(5–6): 549–55.

https://doi.org/10.1007/BF00374921. PMID: 8255740.

23. Killeen S., Gunn J., Hartley J. Surgical management of complicated and medically refractory inflammatory bowel disease during pregnancy. Color Dis. 2017; 19(2): 123–38.

https://doi.org/10.1111/codi.13413. PMID: 27317641.

24. Winter R., Norgard B.M., Friedman S. Treatment of the pregnant patient with inflammatory bowel disease. Inflamm Bowel Dis. 2016; 22(3): 733–44.

https://doi.org/10.1097/MIB.0000000000000625. PMID: 26658216.

25. Friedman S. Gestational weight gain: A new factor influencing pregnancy outcomes in women with inflammatory bowel disease. Dig Dis Sci. 2017; 62(8): 2070–71.

https://doi.org/10.1007/s10620-017-4635-6. PMID: 28577246.

26. Beaulieu D.B., Kane S. Inflammatory bowel disease in pregnancy. Gastroenterol Clin N Am. 2011; 40(2): 399–413, ix.

https://doi.org/10.1016/j.gtc.2011.03.006. PMID: 21601787.

27. Cornish J., Tan E., Teare J. et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy. Gut. 2007; 56(6): 830–37.

https://doi.org/10.1136/gut.2006.108324. PMID: 17185356. PMCID: PMC1954859.

28. Leung Y.P., Kaplan G.G., Coward S. et al. Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease. J Crohns Colitis. 2015; 9(3): 223–30.

https://doi.org/10.1093/ecco-jcc/jjv006. PMID: 25576754.

29. Lin K., Martin C.F., Dassopoulos T. et al. 2 pregnancy outcomes amongst mothers with inflammatory bowel disease exposed to systemic cortico-steroids: Results of the PIANO registry. Gastroenterology. 2014; 146(5): S-1.

https://doi.org/10.1016/S0016-5085(14)60002-0.

30. Truta B. Potential risks of immunosuppressant drugs to the pregnant patient: ACG/Radhika Srinivasan Gender-Based Research Award: 2322. Am J Gastroenterol. 2015; 110: S966.

31. Mitchell K., Kaul M., Clowse M. The management of rheumatic diseases in pregnancy. Scand J Rheumatol. 2010; 39(2): 99–108.

https://doi.org/10.3109/03009740903449313. PMID: 20337545. PMCID: PMC3724464.

32. Broms G., Granath F., Linder M. et al. Complications from inflammatory bowel disease during pregnancy and delivery. Clin Gastroenterol Hepatol. 2012; 10(11): 1246–52.

https://doi.org/10.1016/j.cgh.2012.08.018. PMID: 22922307.

33. Bates S.M., Rajasekhar A., Middeldorp S. et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: Venous thromboembolism in the context of pregnancy. Blood Adv. 2018; 2(22): 3317–59.

https://doi.org/10.1182/bloodadvances.2018024802. PMID: 30482767. PMCID: PMC6258928.

34. van der Woude C.J., Ardizzone S., Bengtson M.B. et al. European Crohn’s and Colitis Organization. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. J Crohns Colitis. 2015; 9(2): 107–24.

https://doi.org/10.1093/ecco-jcc/jju006. PMID: 25602023.

35. Tsigkas G., Davlouros P., Despotopoulos S. et al. Inflammatory bowel disease: A potential risk factor for coronary artery disease. Angiology. 2017; 68(10): 845–49.

https://doi.org/10.1177/0003319717690993. PMID: 28122463.

36. Tandon P., Leung K., Yusuf A., Huang V.W. Noninvasive methods for assessing inflammatory bowel disease activity in pregnancy: A systematic review. J Clin Gastroenterol. 2019; 53(8): 574–81.

https://doi.org/10.1097/MCG.0000000000001244. PMID: 31306343.

37. Julsgaard M., Hvas C.L., Gearry R.B. et al. Fecal calprotectin is not affected by pregnancy: Clinical implications for the management of pregnant patients with inflammatory bowel disease. Inflamm Bowel Dis. 2017; 23(7): 1240–46.

https://doi.org/10.1097/MIB.0000000000001136. PMID: 28498159.

38. Balint A., Berenyi A., Farkas K. et al. Pregnancy does not affect fecal calprotectin concentration in healthy women. Turk J Gastroenterol. 2017; 28(3): 171–75.

https://doi.org/10.5152/tjg.2017.16711. PMID: 28336498.

39. Kammerlander H., Nielsen J., Kjeldsen J. et al. Fecal calprotectin during pregnancy in women with moderate-severe inflammatory bowel disease. Inflamm Bowel Dis. 2018; 24(4): 839–48.

https://doi.org/10.1093/ibd/izx055. PMID: 29506137.

40. Ludvigsson J.F., Lebwohl B., Ekbom A. et al. Outcomes of pregnancies for women undergoing endoscopy while they were pregnant: A nationwide cohort study. Gastroenterology. 2017; 152(3): 554–63.e9.

https://doi.org/10.1053/j.gastro.2016.10.016. PMID: 27773807.

41. Ray J.G., Vermeulen M.J., Aditya Bharatha A. et al. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016; 316(9): 952–61.

https://doi.org/10.1001/jama.2016.12126. PMID: 27599330.

42. Reddy D., Murphy S.J., Kane S.V. et al. Relapses of inflammatory bowel disease during pregnancy: In-hospital management and birth outcomes. Am J Gastroenterol. 2008; 103(5): 1203–9.

https://doi.org/10.1111/j.1572-0241.2007.01756.x. PMID: 18422816.

43. Ghalandari N., Dolhain R.J.E.M., Hazes J.M.W. et al. The pre- and post- authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation. Br J Clin Pharmacol. 2020; 86(3): 580–90.

https://doi.org/10.1111/bcp.14145. PMID: 31633830. PMCID: PMC7080638.

44. Kammerlander H., Nielsen J., Knudsen T. et al. Anti-TNF-α use during the third trimester of pregnancy in women with moderate-severe inflammatory bowel disease and the risk of preterm birth and low birth weight. Inflamm Bowel Dis. 2017; 23(11): 1916–23.

https://doi.org/10.1097/MIB.0000000000001234. PMID: 28858070.

45. Mahadevan U., Vermeire S., Lasch K. et al. Vedolizumab exposure in pregnancy: Outcomes from clinical studies in inflammatory bowel disease. Aliment Pharmacol Ther. 2017; 45(7): 941–50.

https://doi.org/10.1111/apt.13960. PMID: 28169436.

46. Moens A., van der Woude C.J., Julsgaard M. et al. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: Results of the European CONCEIVE study. Aliment Pharmacol Ther. 2020; 51(1): 129–38.

https://doi.org/10.1111/apt.15539. PMID: 31692017.

47. Gotestam Skorpen C., Hoeltzenbein M., Tincani A. et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016; 75(5): 795–810.

https://doi.org/10.1136/annrheumdis-2015-208840. PMID: 26888948.

48. Venturin C., Nancey S., Danion P. et al. Fetal death in utero and miscarriage in a patient with Crohn’s disease under therapy with ustekinumab: Case-report and review of the literature. BMC Gastroenterol. 2017; 17(1): 80.

https://doi.org/10.1186/s12876-017-0633-6. PMID: 28629323. PMCID: PMC5477379.

49. Klenske E., Osaba L., Nagore D. et al. Drug levels in the maternal serum, cord blood and breast milk of a ustekinumab-treated patient with Crohn’s disease. J Crohns Colitis. 2019; 13(2): 267–69.

https://doi.org/10.1093/ecco-jcc/jjy153. PMID: 30388211.

50. Mahadevan U., Dubinsky M.C., Su C. et al. Outcomes of pregnancies with maternal/paternal exposure in the tofacitinib safety databases for ulcerative colitis. Inflamm Bowel Dis. 2018; 24(12): 2494–500.

https://doi.org/10.1093/ibd/izy160. PMID: 29982686. PMCID: PMC6262193.

51. Mahadevan U., Robinson C., Bernasko N. et al. Inflammatory bowel disease in pregnancy clinical care pathway: A report from the American Gastroenterological Association IBD parenthood project working group. Gastroenterology. 2019; 25(4): 627–41.

https://doi.org/1010.1053/j.gastro.2018.12.022. PMID: 30821832.

52. Nielsen O.H., Maxwell C., Hendel J. IBD medications during pregnancy and lactation. Nat Rev Gastroenterol Hepatol. 2014; 11(2): 116–27.

https://doi.org/1010.1038/nrgastro.2013.135. PMID: 23897285.

53. Plauborg A.V., Hansen A.V., Garne E. Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease. Birth Defects Res A Clin Mol Teratol. 2016; 106(6): 494–99.

https://doi.org/1010.1002/bdra.23509. PMID: 27301563.